| Identification | Back Directory | [Name]
1,8-Naphthyridine-3-carbonitrile, 7-(3-chloro-2-fluoro-6-hydroxyphenyl)-6-fluoro-1,2-dihydro-1-[4-methyl-2-(1-methylethyl)-3-pyridinyl]-2-oxo-4-[4-(1-oxo-2-propen-1-yl)-1-piperazinyl]- | [CAS]
2650550-87-9 | [Synonyms]
KRAS G12C inhibitor 35
1,8-Naphthyridine-3-carbonitrile, 7-(3-chloro-2-fluoro-6-hydroxyphenyl)-6-fluoro-1,2-dihydro-1-[4-methyl-2-(1-methylethyl)-3-pyridinyl]-2-oxo-4-[4-(1-oxo-2-propen-1-yl)-1-piperazinyl]- | [Molecular Formula]
C31H27ClF2N6O3 | [MOL File]
2650550-87-9.mol | [Molecular Weight]
605.03 |
| Hazard Information | Back Directory | [Uses]
KRAS G12C inhibitor 35 is a potent inhibitor of KRAS G12C. The Ras family of proteins is an important intracellular signaling molecule that plays an important role in growth and development. KRAS G12C inhibitor 35 has the potential for the research of KRAS G12C-mediated cancer (extracted from patent CN112920183A, compound 3)[1]. | [References]
[1] Liwen Zhao, et al. Compounds as kras-g12c inhibitors and their applications. Patent CN112920183A. |
|
|